217 related articles for article (PubMed ID: 9575159)
1. Activation of thrombin-activable fibrinolysis inhibitor requires epidermal growth factor-like domain 3 of thrombomodulin and is inhibited competitively by protein C.
Kokame K; Zheng X; Sadler JE
J Biol Chem; 1998 May; 273(20):12135-9. PubMed ID: 9575159
[TBL] [Abstract][Full Text] [Related]
2. Elements of the primary structure of thrombomodulin required for efficient thrombin-activable fibrinolysis inhibitor activation.
Wang W; Nagashima M; Schneider M; Morser J; Nesheim M
J Biol Chem; 2000 Jul; 275(30):22942-7. PubMed ID: 10801821
[TBL] [Abstract][Full Text] [Related]
3. Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor.
Bajzar L; Nesheim M; Morser J; Tracy PB
J Biol Chem; 1998 Jan; 273(5):2792-8. PubMed ID: 9446587
[TBL] [Abstract][Full Text] [Related]
4. Activation of protein C and thrombin activable fibrinolysis inhibitor on cultured human endothelial cells.
Wu C; Kim PY; Swystun LL; Liaw PC; Weitz JI
J Thromb Haemost; 2016 Feb; 14(2):366-74. PubMed ID: 26663133
[TBL] [Abstract][Full Text] [Related]
5. Amino acid residues in the P6-P'3 region of thrombin-activable fibrinolysis inhibitor (TAFI) do not determine the thrombomodulin dependence of TAFI activation.
Schneider M; Nagashima M; Knappe S; Zhao L; Morser J; Nesheim M
J Biol Chem; 2002 Mar; 277(12):9944-51. PubMed ID: 11786552
[TBL] [Abstract][Full Text] [Related]
6. VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow.
van Moorsel MVA; Poolen GC; Koekman CA; Verhoef S; de Maat S; Barendrecht A; van Kleef ND; Meijers JCM; Schiffelers RM; Maas C; Urbanus RT
J Thromb Haemost; 2022 May; 20(5):1213-1222. PubMed ID: 35170225
[TBL] [Abstract][Full Text] [Related]
7. Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin.
Mosnier LO
J Biol Chem; 2011 Jan; 286(1):502-10. PubMed ID: 21041299
[TBL] [Abstract][Full Text] [Related]
8. Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties.
Boffa MB; Wang W; Bajzar L; Nesheim ME
J Biol Chem; 1998 Jan; 273(4):2127-35. PubMed ID: 9442053
[TBL] [Abstract][Full Text] [Related]
9. Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains.
Hall SW; Nagashima M; Zhao L; Morser J; Leung LL
J Biol Chem; 1999 Sep; 274(36):25510-6. PubMed ID: 10464282
[TBL] [Abstract][Full Text] [Related]
10. Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway.
Bajzar L
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2511-8. PubMed ID: 11116046
[TBL] [Abstract][Full Text] [Related]
11. Identification of the epidermal growth factor-like domains of thrombomodulin essential for the acceleration of thrombin-mediated inactivation of single-chain urokinase-type plasminogen activator.
Schenk-Braat EA; Morser J; Rijken DC
Eur J Biochem; 2001 Nov; 268(21):5562-9. PubMed ID: 11683879
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage.
Marx PF; Hackeng TM; Dawson PE; Griffin JH; Meijers JC; Bouma BN
J Biol Chem; 2000 Apr; 275(17):12410-5. PubMed ID: 10777524
[TBL] [Abstract][Full Text] [Related]
13. Functional domains of membrane-bound human thrombomodulin. EGF-like domains four to six and the serine/threonine-rich domain are required for cofactor activity.
Tsiang M; Lentz SR; Sadler JE
J Biol Chem; 1992 Mar; 267(9):6164-70. PubMed ID: 1313430
[TBL] [Abstract][Full Text] [Related]
14. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex.
Bajzar L; Morser J; Nesheim M
J Biol Chem; 1996 Jul; 271(28):16603-8. PubMed ID: 8663147
[TBL] [Abstract][Full Text] [Related]
15. The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complex.
Wu C; Kim PY; Manuel R; Seto M; Whitlow M; Nagashima M; Morser J; Gils A; Declerck P; Nesheim ME
J Biol Chem; 2009 Mar; 284(11):7059-67. PubMed ID: 19074424
[TBL] [Abstract][Full Text] [Related]
16. Lys 42/43/44 and Arg 12 of thrombin-activable fibrinolysis inhibitor comprise a thrombomodulin exosite essential for its antifibrinolytic potential.
Wu C; Stafford AR; Fredenburgh JC; Weitz JI; Gils A; Declerck PJ; Kim PY
Thromb Haemost; 2017 Jul; 117(8):1509-1517. PubMed ID: 28640323
[TBL] [Abstract][Full Text] [Related]
17. Identification of a thrombomodulin interaction site on thrombin-activatable fibrinolysis inhibitor that mediates accelerated activation by thrombin.
Marar TT; Boffa MB
J Thromb Haemost; 2016 Apr; 14(4):772-83. PubMed ID: 26816270
[TBL] [Abstract][Full Text] [Related]
18. Pig thrombomodulin binds human thrombin but is a poor cofactor for activation of human protein C and TAFI.
Roussel JC; Moran CJ; Salvaris EJ; Nandurkar HH; d'Apice AJ; Cowan PJ
Am J Transplant; 2008 Jun; 8(6):1101-12. PubMed ID: 18444940
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies against human thrombomodulin whose epitope is located in epidermal growth factor-like domains.
Nawa K; Ono M; Fujiwara H; Sugiyama N; Uchiyama T; Marumoto Y
Biochim Biophys Acta; 1994 Apr; 1205(2):162-70. PubMed ID: 7512385
[TBL] [Abstract][Full Text] [Related]
20. Selective modulation of thrombin-activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin-thrombomodulin complex using TAFI-derived peptides.
Plug T; Marquart JA; Marx PF; Meijers JC
J Thromb Haemost; 2015 Nov; 13(11):2093-101. PubMed ID: 26341360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
